HIS
MYGN icon

Harvest Investment Services’s Myriad Genetics MYGN Stock Holding History

Harvest Investment Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,618
Closed -$595K – 179
2022
Q1 		$595K Sell
23,618
-10,457
-31% -$268K 0.36% 80
2021
Q4 		$940K Buy
34,075
+9,724
+40% +$282K 0.4% 70
2021
Q3 		$786K Buy
24,351
+3,092
+15% +$103K 0.32% 97
2021
Q2 		$650K Buy
21,259
+3,129
+17% +$90.4K 0.27% 106
2021
Q1 		$552K Buy
+18,130
New +$515K 0.25% 119

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Harvest Investment Services's MYGN Position: Q2 2022 in Review

Harvest Investment Services sold out of Myriad Genetics (MYGN) in Q2 2022, closing a stake of 23,618 shares — an estimated $595K sold.

Harvest Investment Services first reported a position in MYGN in Q1 2021 and held it in 5 quarters. The position peaked at $940K in Q4 2021. 198 funds tracked by Wall St. Rank hold MYGN as of Q2 2022.

  • Harvest Investment Services reported no remaining Myriad Genetics position as of Q2 2022 after selling out during the quarter.
  • Harvest Investment Services sold 23,618 Myriad Genetics shares in Q2 2022, an estimated $595K.
  • Harvest Investment Services first reported a position in Myriad Genetics in Q1 2021 and held it in 5 quarters.
  • Harvest Investment Services's Myriad Genetics position peaked at $940K in Q4 2021.
  • 198 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2022.

Based on Harvest Investment Services's 13F filing for Q2 2022, filed 19 Jul 2022.